Hostname: page-component-77c89778f8-7drxs Total loading time: 0 Render date: 2024-07-19T23:33:59.287Z Has data issue: false hasContentIssue false

Profile of patients undergoing treatment with long-acting injectable antipsychotic drugs in a psychiatry hospital in Portugal

Published online by Cambridge University Press:  19 July 2023

J. R. P. Correia*
Affiliation:
Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde do Nordeste, Bragança, Portugal
R. A. Moreira
Affiliation:
Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde do Nordeste, Bragança, Portugal
E. Maldonado
Affiliation:
Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde do Nordeste, Bragança, Portugal
H. J. Gomes
Affiliation:
Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde do Nordeste, Bragança, Portugal
J. R. Gomes
Affiliation:
Departamento de Psiquiatria e Saúde Mental, Unidade Local de Saúde do Nordeste, Bragança, Portugal
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The treatment with long-acting injectable antipsychotics (LAIAs) is more and more frequent and it shows advantages regarding adherence, effectiveness and tolerance.

Objectives

To describe and compare the profile of patients under treatment with LAIAs in a psychiatric hospital in Portugal.

Methods

An observational and retrospective study was carried out with the collection of data referring to patients hospitalized with a first psychotic episode between 01/01/2019 and 30/06/2022 in a psychiatric hospital in Portugal and the respective evaluation of sociodemographic and clinical data through the information recorded in the clinical files.

Results

During the 42 months of the study, we selected 78 patients who presented psychotic symptoms on admission. Patients with a history of previous psychotic episodes and prescription of antipsychotic therapy prior to hospitalization were excluded.

Of 78 patients hospitalized with a first psychotic episode, 34 - which corresponds to approximately 44% - were discharged with LAIAs.

Patients receiving LAIAs had an average age of 39 years. The average number of days of hospitalization was 28 days; 41% were female (n=14) and 59 were male (n=20); 35% (n=12) consumed psychoactive substances previously on admission to hospital; 62% (n=21) were discharged under the compulsive treatment regimen. Regarding the diagnosis at discharge, based on the international classification of disease-11 (ICD-11), the most common were schizophrenia, psychotic disorder induced by psychoactive substances and acute and transient psychotic disorder.

From the statistical analysis carried out, no correlation was observed between the rate of readmissions and the administration of LAIAs, nor was there any correlation between the rate of readmissions and compulsive outpatient treatment.

Conclusions

Despite what is described in the literature, in the sample under study, the LAIAs were not superior in the variables studied, namely in reducing the readmission rate. Possible explanations for the results obtained may be justified by the size of the sample under study and the follow-up time of the cases.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.